Perspectives on Rheumatoid Arthritis for the Orthopedic Surgeon: Overview of Early Diagnosis and the Tumor Necrosis Factor Antagonists

rheumatoid arthritis; arthritis, cyclic citrullinated peptide antibodies; tumor necrosis factor antagonists; disease modifying antirheumatic drug, DMARD, Perspectives on Rheumatoid Arthritis for the Orthopedic Surgeon: Overview of Early Diagnosis and the Tumor Necrosis Factor Antagonists; Keith; The American Journal of Orthopedics, AJO

rheumatoid arthritis; arthritis, cyclic citrullinated peptide antibodies; tumor necrosis factor antagonists; disease modifying antirheumatic drug, DMARD, Perspectives on Rheumatoid Arthritis for the Orthopedic Surgeon: Overview of Early Diagnosis and the Tumor Necrosis Factor Antagonists; Keith; The American Journal of Orthopedics, AJO

rheumatoid arthritis; arthritis, cyclic citrullinated peptide antibodies; tumor necrosis factor antagonists; disease modifying antirheumatic drug, DMARD, Perspectives on Rheumatoid Arthritis for the Orthopedic Surgeon: Overview of Early Diagnosis and the Tumor Necrosis Factor Antagonists; Keith; The American Journal of Orthopedics, AJO